Academic Journal
Q1Inflammation Research
About Inflammation Research
Inflammation Research is a scholarly journal published by Springer Science and Business Media Deutschland GmbH. SCImago 2025 lists it in Q1, with an SJR of 1.552 and H-index of 117.
Coverage: 1995-2026. Research categories: Immunology (Q1); Pharmacology (Q1).
Verified field sources
- Journal Impact Factor: 6.2 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): John A. Di Battista BSc, MSc, PhD (Editor-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Mast cells and histamine; Asthma and respiratory diseases; Immune Response and Inflammation; Inflammatory mediators and NSAID effects; Receptor Mechanisms and Signaling; Polyamine Metabolism and Applications.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,790.00 USD; 3,790.00 EUR; 2,990.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
MLN4924 suppresses kidney renal clear cell carcinoma progression through coordinated inhibition of Cullin1 neddylation and PSMB10-associated NF-κB inflammatory signaling
Dequan Liu, Jing Su, Feng Chen, Lei Liu et al.
2026-09-27 · DOI: 10.1007/s00011-026-02363-xInterferon-mediated regulation of the neurovascular unit in diabetic retinopathy
Haoyang Yu, Liqing Xie, Wenjian Lin
2026-09-27 · DOI: 10.1007/s00011-026-02369-5ADAM19: biological characteristics and implications in disease pathology and clinical applications
Yichun Hu, Xuehan Wang, Yang Qu, Deyuan Li et al.
2026-09-27 · DOI: 10.1007/s00011-026-02340-4PP4 deficiency drives airway epithelial senescence via the PERK-eIF2α-ATF4-p21 axis in severe asthma
Yu-Ting Huang, Chu-Yun Chen, Chih-Ming Weng, Shao-An Wang et al.
2026-09-27 · DOI: 10.1007/s00011-026-02378-4Machine learning-driven M2 macrophage signature for precision prediction of survival and therapy response in acute myeloid leukemia
Fangmin Zhong, Jing Liu, Jingze Yue, Linlin Zhang et al.
2026-09-27 · DOI: 10.1007/s00011-026-02379-3Multi-omics characterization of Yao syndrome identifies three pathophysiological axes and disease-specific divergence from Blau syndrome
Jingyuan Zhang, Xin Huang, Guishan Liu, Xuan Zhou et al.
2026-09-24 · DOI: 10.1007/s00011-026-02355-xLoss of C3 and CD14 reduces region-specific neuroinflammation in a murine polytrauma model
Florian Olde Heuvel, Marica Pagliarini, Fan Sun, Ludmila Lupu et al.
2026-09-24 · DOI: 10.1007/s00011-026-02367-7UBE2L6 drives ulcerative colitis progression by promoting BIRC2 degradation and activating non-canonical NF-κB signalling
Zhiyi Cheng, Chao Yu, Guiyuan Liu, Bingbing Su et al.
2026-09-24 · DOI: 10.1007/s00011-026-02364-wRetraction Note: N‑Pyrazoloyl and N‑thiopheneacetyl hydrazone of isatin exhibited potent anti‑inflammatory and anti‑nociceptive properties through suppression of NF‑κB, MAPK and oxidative stress signaling in animal models of inflammation
Sara Zeeshan, Muhammad Naveed, Adnan Khan, Ayesha Atiq et al.
2026-09-23 · DOI: 10.1007/s00011-026-02382-8Targeting USP47 reprograms macrophage polarization to ameliorate septic peritonitis and promote cutaneous wound healing
Hu Lei, Li Yang, Hanzhang Xu, Yingying Wang et al.
2026-09-19 · DOI: 10.1007/s00011-026-02380-wIdentification of immune cell mitochondrial dysfunction characteristics and clinical predictive biomarkers in sepsis via multi-cohort machine learning and single-cell RNA sequencing
Xin Le, Youfen Fan, Sida Xu, Jiliang Li et al.
2026-09-19 · DOI: 10.1007/s00011-026-02366-8The IL-4/IL-4R/STAT6 signaling axis regulates macrophage efferocytosis in osteoarthritis
Haiping Zhang, Ziliang Yu, Dagong Gao, Fei Xia et al.
2026-09-19 · DOI: 10.1007/s00011-026-02376-6Phenotypic switching of gastrointestinal smooth muscle cells and the regulatory role of macrophages: a literature review
Jinfei Fan, Yue Jiang, Xinchi Luan, Xuezhe Wang et al.
2026-09-19 · DOI: 10.1007/s00011-026-02360-0STAT1: a central hub linking ferroptosis and inflammation in hepatic ischemia–reperfusion injury
Chenxi Li, Yan Chen, Zhengye Wang, Yuchen Ni et al.
2026-09-17 · DOI: 10.1007/s00011-026-02370-yThe role of mTORC2/RICTOR in immune cells and inflammatory diseases
Jingting Xu, Wenxin Zhong, Fei Xin, Fei Xu et al.
2026-09-17 · DOI: 10.1007/s00011-026-02365-9Discovery and validation of novel plasma protein biomarkers for severe tuberculosis patients
Yifan Hu, Yu Xue, Wei Shu, Weicong Ren et al.
2026-09-14 · DOI: 10.1007/s00011-026-02362-yOld drug with new application: spironolactone suppresses Panx 1-mediated Ca2+ influx to attenuate inflammation-driven neutral lipid accumulation in early atherosclerosis
Yang Yang, Tianyi Gu, Mengxue Zheng, Qiushi Huang et al.
2026-09-14 · DOI: 10.1007/s00011-026-02361-zMajor cardiovascular event risk of advanced therapies in inflammatory bowel diseases: systematic review and meta-analysis
Amirah H. Alnahdi, Chelsea Salmon, Fanxing Du, Mikael Svensson et al.
2026-09-14 · DOI: 10.1007/s00011-026-02336-0Autoimmune processes and production of catalytically active antibodies-abzymes in prone to amyotrophic lateral sclerosis FUS(1-359) mice
Andrey E. Urusov, Marina A. Gorobets, Kseniya S. Aulova, Anna M. Timofeeva et al.
2026-09-14 · DOI: 10.1007/s00011-026-02358-8Single-cell RNA profiling suggests goflikicept-mediated immune modulation in idiopathic recurrent pericarditis
A. Golovkin, E. Markelova, E. V. Ignatieva, O. Kalinina et al.
2026-09-14 · DOI: 10.1007/s00011-026-02347-xReviews
Community Reviews
Version History
October 4, 2026 at 8:51 pm
September 25, 2026